Smith+Nephew is a leading portfolio medical technology company. Since 1856, when our founder T.J. Smith developed a new method for refining cod liver oil, and in World War One when his nephew led the supply of wound care products, to the present day, Smith & Nephew continues to pioneer health solutions. Through our market leadership positions in Sports Medicine, Orthopaedic Reconstruction and Advanced Wound Management, our 17,500+ employees continue to improve outcomes and expand access. We are a constituent of the UK’s FTSE100 and our shares are traded on London Stock Exchange and through American Depository Receipts on the New York Stock Exchange (LSE: SN,NYSE:SNN). Please note: not all products referred to may be approved for use or available in all markets.